Medigus to Acquire 60% Interest of Commercial Property in Miami
28 Septiembre 2023 - 8:23AM
Medigus Ltd. (Nasdaq: MDGS) (“Medigus” or the “Company”), a
technology company engaged in a technology company engaged in
innovative internet technologies, electric vehicle and charging
solutions and advanced medical solutions , announced today it has
signed an operating agreement with a US-based partner, specializing
in acquiring, improving, renovating, developing and selling
commercial properties in Miami (the “Partner”) for the formation of
a joint venture (“JV”), that will purchase, renovate, manage and
sell a commercial property in Miami, Florida, USA. The formation of
the JV is contingent upon the property’s acquisition by
mid-October.
The property consists of 3 parcels containing
land of approximately 19,000 square feet which consists of a one
2-story building containing 9,000 square feet, and a one-story
building containing 2,800 square feet. The property has additional
development rights, and subject to approvals and permits, could
result in additional stories.
The initial capital contribution paid by Medigus
is $2 million and its initial percentage interest in the JV is 60%,
while the Partner interest is 40%. According to the operating
agreement, Medigus has full preference in the JV cash distribution,
and once the initial contribution by Medigus has been fully repaid,
Medigus’ interest in the JV will decrease to 30%.
Medigus intends to continue and explore
additional opportunities in Miami for the purpose of acquiring,
improving, renovating, further developing and selling the
properties, directly or indirectly, through one or more of its
subsidiaries.
According to PwC 2023 Emerging Trends in Real
Estate survey, Miami, FL is ranked first in U.S office property and
U.S retail property to buy, hold and sell recommendations, in
addition to ranking second in U.S Industrial and Hotel properties
to buy, hold and sell recommendations.
According to PropStream, Miami’s population is
growing while unemployment declines, real estate costs are rising
alongside greater availability while more corporations relocating
to Miami and bringing more employees with them.
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is
a technology company focused on innovative growth partnerships,
engaged in innovative internet technologies, electric vehicle and
charging solutions and advanced medical solutions. The Company’s
affiliates in digital commerce include Gix Internet Ltd., Jeffs’
Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle
market, Charging Robotics Ltd. and Revoltz Ltd. by way of Fuel
Doctor Holdings, Inc., and ParaZero Ltd. are also part of the
Company’s portfolio of technology solution providers. Medigus’
affiliation in the medical solutions arena includes ownership in
Polyrizon Ltd.. Medigus is traded on the Nasdaq Capital Market. To
learn more about Medigus’ advanced technologies, please visit
http://www.medigus.com/.
Cautionary Note Regarding Forward Looking
Statements
This press release contains forward-looking
statements within the meaning of the “safe harbor” provisions of
the Private Securities Litigation Reform Act of 1995 and other
Federal securities laws. Words such as “expects,” “anticipates,”
“intends,” “plans,” “believes,” “seeks,” “estimates” and similar
expressions or variations of such words are intended to identify
forward-looking statements. Because such statements deal with
future events and are based on Medigus’ current expectations, they
are subject to various risks and uncertainties, and actual results,
performance or achievements of Medigus could differ materially from
those described in or implied by the statements in this press
release. For example, Medigus uses forward looking statements
when it discusses its intention to investigate further
opportunities in the Miami market and when it refers the expected
acquisition of the property under the operating agreement and its
potential prospects.
The forward-looking statements contained or
implied in this press release are subject to other risks and
uncertainties, including those discussed in any filings with the
SEC. Except as otherwise required by law, Medigus undertakes no
obligation to publicly release any revisions to these
forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrence of unanticipated
events. References and links to websites have been provided as a
convenience, and the information contained on such websites is not
incorporated by reference into this press release. Medigus is not
responsible for the contents of third-party websites.th
Company Contact: Tali Dinar Chief Financial Officer
+972-8-6466-880 ir@medigus.com
Medigus (NASDAQ:MDGS)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Medigus (NASDAQ:MDGS)
Gráfica de Acción Histórica
De May 2023 a May 2024